That's an excellent detailed report.
It appears that RCE will be taken over by 2028 for circa AUD $15B. I think it will be either Roche or J&J. Will be small change for them.
With dilution I forecast about 300M SOI & $15B takeover price = $50 SP.
The report has forecast $3.66B revenue by FY32 @ 70% EBIT = $2.56B x 0.7 = $1.79B NPAT x PE50 = $89.67B MC.
[VIDEO] Recce Pharma (ASX:RCE) selects CMAX for phase I/II UTI clinical trial, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.080(21.9%) |
Mkt cap ! $128.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 44.5¢ | 37.5¢ | $191.2K | 477.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12222 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 10976 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |